National Cancer Institute; Notice of Closed Meetings, 39713-39714 [2012-16339]
Download as PDF
Federal Register / Vol. 77, No. 129 / Thursday, July 5, 2012 / Notices
Dated: June 27, 2012.
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–16350 Filed 7–3–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
TKELLEY on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; Review of RFA AA–12–010.
Date: July 18, 2012.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIH, 5635 Fishers Lane, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch
EPRB, NIAAA, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@mail.
nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member conflict
SEP—Neurosciences.
Date: July 25, 2012.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
MSC9304, 5635 Fishers Lane, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch
EPRB, NIAAA, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@mail.
nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict
Reviews—Biosciences.
Date: July 30, 2012.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
16:48 Jul 03, 2012
Jkt 226001
Place: National Institutes of Health, 5635
Fishers Lane, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch
EPRB, NIAAA, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@mail.
nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict
applications Clinical and Treatment Related
Applications.
Date: August 2, 2012.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch
EPRB, NIAAA, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@mail.
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: June 26, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–16340 Filed 7–3–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Feasibility
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
39713
Studies for Collaborative Interaction for
Minority Institution/Cancer Center
Partnership.
Date: July 10–11, 2012.
Time: 7 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Gerald G. Lovinger, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Room 8101, Bethesda,
MD 20892–8329, 301–496–7987,
lovingeg@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer
Institute Special Emphasis Panel; R13
Application Review.
Date: July 17, 2012.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Bratin K. Saha, Ph.D.,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8041, Bethesda, MD 20892, 301–402–
0371, sahab@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer
Institute Special Emphasis Panel; R01 and
R03 Grant Applications.
Date: July 17, 2012.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Cancer Institute, 6116 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Olivia Bartlett, Ph.D.,
Chief, Research Programs Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 6116 Executive Blvd.,
Room 8121, Bethesda, MD 20892–7405, 301–
594–2501, op2t@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Institutional Training and Education Grants.
Date: July 24, 2012.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Cancer Institute, 6116 Executive
Boulevard, Room 707, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Timothy C. Meeker, MD,
Ph.D., Scientific Review Officer, Resources
E:\FR\FM\05JYN1.SGM
05JYN1
39714
Federal Register / Vol. 77, No. 129 / Thursday, July 5, 2012 / Notices
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8103, Bethesda, MD 20892, (301) 594–
1279, meekert@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: June 26, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
TKELLEY on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Complex Phenotypes.
Date: July 24, 2012.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3An12, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Lisa A. Dunbar, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An12, Bethesda, MD
20892, 301–594–2849, dunbarl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
16:48 Jul 03, 2012
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 26, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2012–16338 Filed 7–3–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
[FR Doc. 2012–16339 Filed 7–3–12; 8:45 am]
VerDate Mar<15>2010
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases, Special Emphasis Panel, Clinical
Trials Applications.
Date: July 25, 2012.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Helen Lin, Ph.D.,
Scientific Review Officer, National Institute
of Arthritis, Musculoskeletal and Skin
Diseases, National Institutes of Health, 6701
Democracy Blvd., Suite 800, MSC 4872,
Bethesda, MD 20892, 301–594–4952,
linh1@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: June 25, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
A—Cancer Centers.
Date: August 3, 2012.
Time: 8:00 a.m. to 4:50 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Gail J. Bryant, MD,
Medical Officer, Resources and Training
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Room 8107, MSC 8328,
Bethesda, MD 20892–8328, (301) 402–0801,
gb30t@nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/irg/irg.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: June 26, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–16336 Filed 7–3–12; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2012–16337 Filed 7–3–12; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00040
Fmt 4703
Sfmt 9990
E:\FR\FM\05JYN1.SGM
05JYN1
Agencies
[Federal Register Volume 77, Number 129 (Thursday, July 5, 2012)]
[Notices]
[Pages 39713-39714]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-16339]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Feasibility Studies for Collaborative Interaction for
Minority Institution/Cancer Center Partnership.
Date: July 10-11, 2012.
Time: 7 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd.,
Room 8101, Bethesda, MD 20892-8329, 301-496-7987,
lovingeg@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer Institute Special Emphasis
Panel; R13 Application Review.
Date: July 17, 2012.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6120 Executive Blvd.,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Bratin K. Saha, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Boulevard, Room 8041, Bethesda, MD 20892, 301-402-0371,
sahab@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer Institute Special Emphasis
Panel; R01 and R03 Grant Applications.
Date: July 17, 2012.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Cancer Institute,
6116 Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Olivia Bartlett, Ph.D., Chief, Research Programs
Review Branch, Division of Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Room 8121, Bethesda, MD 20892-
7405, 301-594-2501, op2t@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Institutional Training and Education Grants.
Date: July 24, 2012.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Cancer Institute,
6116 Executive Boulevard, Room 707, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Timothy C. Meeker, MD, Ph.D., Scientific Review
Officer, Resources
[[Page 39714]]
and Training Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8103,
Bethesda, MD 20892, (301) 594-1279, meekert@mail.nih.gov.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: June 26, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-16339 Filed 7-3-12; 8:45 am]
BILLING CODE 4140-01-P